Objective-To evaluate the influence on compliance of demographic variables and of the way of proposing a faecal occult blood test in a colorectal cancer mass screening programme. Setting-Well defined population in Burgundy (France). Methods-From 1988 to 1996 five screening rounds were conducted in people aged 45 to 74 on entering the study. The screening test was provided free of charge by primary care physicians over a four month period, then mailed to nonconsultants, followed by a potential reminder letter. The whole population was invited to participate in each screening campaign.
Together with the efficacy of a screening test, compliance is the major determinant in the effectiveness of a screening programme. Even a highly sensitive screening test will be ineffective if few people actually accept it. Compliance must be high at the initial screening and at subsequent rescreenings at regular intervals.
Colorectal cancer meets the criteria necessary for it to be considered for population based screening. I Although endoscopy has been recommended by some organisations, the test most commonly used and evaluated in colorectal cancer screening is the faecal occult blood test.' 3 Population compliance is uncertain when it comes to endoscopy screening, whereas it is well established that a high proportion of the population can be persuaded to take a faecal occult blood test regularly.' The acceptability of this screening strategy varies greatly from one study to another, however, depending on population attitudes towards screening and on methods of approach to the public. This study aimed at evaluating :the influence of the population's demographic characteristics, and the way of proposing the test, on participation in a French mass screening programme to determine a screening strategy adapted to this population.
Patients and methods

STUDY DESIGN
All the residents of 12 administrative districts of the department of Saone-et-Loire (Burgundy), born between 1914 and 1943, were invited to participate in a mass screening programme for colorectal cancer. A faecal occult blood test, the Haemoccult test, was used as a screening test. Overall, 26 801 subjects took part in 1988 and 18 841 in 1989. The screening campaigns were repeated for the whole population in 1990, 1992, 1994, and 1996 . Each screening campaign took place between January and mid-July. This analysis is part of a controlled study aimed at evaluating the efficacy and cost effectiveness of mass screening for colorectal cancer, which will continue for 10 years-that is, until 1998.
All screening campaigns were set up by researchers at the Burgundy Cancer Registry, who were in charge of the design and analysis of the screening programme, in collaboration with primary care physicians and gastroenterologists. The 180 GPs and 22 doctors in occupational medicine covering the population taking part in the study met in three groups. Firstly, they obtained information on colorectal cancer and on screening problems. They then helped with the study design, particularly in drawing up the document meant to increase public awareness. They were assisted in this by an advertising agency. Because their training needs were different, the gastroenterologists met separately for the first screening campaign and with the GPs thereafter. Information on the screening programme was also mailed to the whole medical profession, nurses, and physiotherapists. Each screening campaign began with sending a letter, signed by the GPs of each administrative district, to each subject invited, together with a four page brochure. The aim was to transmit four main pieces of information: (a) colorectal cancer is a common and severe disease; (b) it can be cured when diagnosed early; (c) a polyp is a precancerous lesion; and (d) occult blood screening can detect early stage cancers and large polyps. At the same time, the screening campaign was advertised in local newspapers, on local radio programmes, and on regional television. Posters on the theme "don't bury your head in the sand like an ostrich" were displayed in GPs' waiting rooms and offices.
As a first step, the Haemoccult test and instructions for use were provided free of charge by primary care physicians over a four month period. Then the test was mailed with a letter of instructions and a postage-paid reply envelope to the people who had not consulted a primary care physician during this period. If, after one month, the test had not been sent back to the central analysis centre, a reminder letter was sent. In a small area (6240 study participants), during the first screening campaign, the test was prescribed on a special document, bought at the chemist's and totally reimbursed by the medical insurance system. This mode of distribution was not continued during succeeding campaigns because of low compliance.
All the population was invited to participate in the successive campaigns. During the fifth screening campaign the Haemoccult test was not mailed to those who had not participated in the four previous ones. They only received a reminder letter. The study participants were asked to provide two faecal samples from three consecutive bowel motions. No diet restriction was demanded. It was only suggested that one should avoid the times of menstrual periods and, if possible, aspirin and vitamin C intake. Tazi, Faivre, Dassonville, Lamour, Milan, Durand In all cases, the subject was asked to send the three completed test cards back to the central analysis centre after having performed the screening test. These were analysed without rehydration according to a standardised procedure. The result was mailed to the subject on the same day and a colonoscopy was proposed when the test was positive.
STATISTICAL ANALYSIS
Compliance was analysed by sex, age group, and place of residence. It was coded as urban (subjects living in towns of more than 2000 inhabitants) or rural areas. The phase of the screening campaign (medical or postal) was also taken into account. The relation between the subjects' characteristics (sex, age, and place of residence) and their participation during the phases of the screening campaign was analysed with a polychotomous logistic regression. This model is an extension of the classical logistic regression using a multinomial distribution. It provides an odds ratio comparing participation only in the medical invitation phase to no participation (in any campaign whatsoever), participation only in the postal invitation phase to no participation, and participation in both medical and postal phases (in different campaigns) to no participation. Owing to the changing age with each campaign, in this analysis we used age at entry into the screening programme. In the univariate analysis all significant variables were introduced into the multivariate model. The analysis was performed after five screening campaigns. We made adjustments according to the number of campaigns for which each person was eligible (one to five campaigns). The significance of covariates was tested by the likelihood ratio test. Computations were performed with BMDP software.
Results
PARTICIPATION IN THE SCREENING CAMPAIGN BY
SEX, AGE, AND PLACE OF RESIDENCE
The overall participation rate in the first screening campaign was 52.8%. It increased slightly over the succeeding campaigns to 54.0% in the second screening campaign, 57.3% in the third, 58.3% in the fourth, and 56.2% in the fifth. Compliance was higher in women than in men (table 1). The relative difference between the sexes was about 10% for all the screening campaigns. The acceptability of the screening test was lower in the youngest and oldest age groups, and was higher among those aged 55 to 69 (table 1) .
Participation rates were lower in rural than in urban areas (table 1). They remained fairly stable in rural areas while they increased in urban areas. The relative difference in participation rates between urban and rural areas varied between 5% and 17%. Differences between urban and rural areas were similar in all age groups. PARTICIPATION (table 4) . Age was independently associated with compliance. The proportion of tests performed on participants in the medical phase alone was higher in those aged 50 to 69 on entry into the study. A similar trend, although less pronounced, was seen in participants in both the medical and mailing phases. It was lower in younger and older subjects. Participation during the mailing phase alone decreased with age. More women participated regardless of the way of participating in the screening campaigns. It was slightly more pronounced in participants in both the medical and mailing phases. More participation was seen in urban area than in rural areas in the medical phases only and, to a lesser degree, in both the medical and mailing phases. Among those participating in the mailing phases only, compliance was similar in both areas. 
Discussion
Achieving a high compliance is essential in a mass screening programme. Not surprisingly, a high compliance has been reported in studies carried out in volunteers.' In North America the target is to obtain high compliance in such groups, so as to decrease mortality from colorectal cancer in screening initiated by volunteers. In Europe the objective is mass population based screening, which aims at decreasing colorectal cancer mortality at a population level. It is considered that recommendations directed towards case findings will have little effect on overall mortality from colorectal cancer, which is why pilot community based programmes have been developed so far. Although compliance is somewhat lower than in volunteers, a high compliance has been obtained in many carefully designed community based programmes in Europe.?" This difference in objectives between American and European situations has generated a misunderstanding among public health specialists. When we examined the overall participation we found that compliance was lower in men than in women. Similar results have previously been reported by others." [7] [8] [9] [10] This difference between men and women, which is only about 10%, can probably be explained by a difference in attitude towards screening campaigns and health matters in general. We found, as other studies have done, a poorer compliance in subjects over 70. 7 11 The results for the youngest age group (45 to 49) are conflicting. We and other studies found a lower participation, but this is not always seen.B 12 Compliance is always higher in the intermediate age group-that is, those aged 50 to 69 on entry into the study. Tazi, Faivre, Dassomnlle, Lamour, Milan, Durand This study also indicates that the participation rate is influenced by the place of residence. Urban-rural differences increased over time, were similar in all age groups, and were mainly related to the medical invitation phase. Such findings have already been reported in Calvados (Normandy), where they were even more pronounced. B These findings are open to different interpretations. They may reflect different patterns of behaviour toward illness, different accessibility of primary care physicians, or less participation by GPs in rural areas. The first suggestion is probably correct as subjects living in rural areas are much less likely to consult their GP than those living in towns."
The way of delivering the screening test affects compliance. It has already been shown several times in France that sending a letter with a specific appointment to get a test free of charge from the GP, the chemist, or from the health centre resulted in an acceptability ofless than 20%. " 15 This method must no longer be used alone. It is well established that in Nordic countries high participation can be achieved by mailing the test then sending one or two reminders. Initial compliance is about 65%, and 85-90% of those having participated in the first screening comply with biennial screening over a 10 year period.' 6 With this method, a slightly lower compliance rate has been reported in England, ranging from 38% to 55%. 16 17 In our study, when mailing the test, compliance rates were much lower, between 26% and 34% according to the screening campaign. Our data suggest that in France this approach cannot be used alone.
Clearly, this study shows that in France the active participation of primary care physicians is crucial to obtain high participation. They must be able to motivate patients to comply with the screening programme and with the requirement of the primary screening test, as well as be sure that all subsequent investigations are carried out. So their training is of great importance for a successful programme. An invitation to participate in a short training session a few days before the start of the screening campaign is not sufficient and a specific organisation is required to motivate GPs. Our experience suggests that meeting in small groups encourages active participation. Also, they must understand the problem of mass screening, the importance of their role, and must take part in planning the screening programme. Regular feedback on the development of the screening programme is also important. When this technique was used active participation of more than 90% of the GPs was obtained. Offering the test during a routine consultation resulted in an average participation rate of 90%. The efficiency of GPs increased after the first screening campaign, probably owing to their greater experience, and then remained fairly constant over time. During the first screening campaign they were able to propose the test to 36% of the resident population over a four month period. During succeeding campaigns they gave the test to 45% of the subjects. GPs seem to be more efficient when they actively propose the test over a short period of time, as was done in Burgundy, than when the distribution is planned over a one or two year period, as was carried out in Calvados. IS Mailing the test was helpful in reaching those who were not in contact with a primary care physician during the medical free offer phase. In France, other studies confirm that these two approaches are necessary.S This strategy may be of interest in southern European countries where participation is low when invitations are mailed out selectively. This is likely to be true in any country where general practice is at the forefront of medical practice. British data suggest that compliance may be higher after a free medical offer than after mailing the test." '0 The overall compliance was also increased by inviting all subjects to participate in screening, regardless of whether or not they had participated in the first screening. This is important as compliance is a key determinant in the cost of detecting cancer by means of screening. Nearly 70% of the invited population participated at least once. The effect of this strategy decreased with repetition of the screening campaign. Few non-participants in the previous screening campaigns started screening on the fourth or fifth one.
The way of proposing the test has to be carefully prepared and evaluated. In the United Kingdom a letter of invitation from a family doctor was more effective than a similar letter from a university department." In view of this the letter of invitation used in our study was signed by all GPs from each administrative area. The value of health educatiorrdocuments varies. In one study an educational document decreased compliance by 9%,21 another study showed no benefit, and in one report the uptake increased by 9%.>0 In our study the educational booklet, together with the explanations given by the GPs, were considered by participants to be the most important influences on participation." The value of educational material depends on its content, and it is important to know how they are perceived by the public. In this study researchers, GPs, and publicists worked together on the design of these documents. To conclude, the success of a mass screening programme depends mainly on an enthusiastic participation by GPs and good promotion to the population. That is why it is essential to understand the factors, especially demographic factors, which may influence compliance in the target population. This information is important as it leads to better organisation of the screening campaign and development of an 151 adapted screening strategy to improve the participation rate. This project was funded by the Europe Against Cancer Programme, the INSERM, the Fond National de prevention, the Burgundy Regional Council, and the French League Against Cancer. We thank the participating general practitioners, gastroenterologists, surgeons, and pathologists, Mrs Brigitte [acquier and Mrs Isabelle Delineau for their assistance in data management, and Pascale O'Sullivan for proofreading this article.
